Journal of Cancer Research and Clinical Oncology

Journal of Cancer Research and Clinical Oncology is the official journal of the German Cancer Society and publishes work across experimental and clinical oncology, founded in 1979.《癌症研究与临床肿瘤学杂志》是德国癌症学会的官方期刊，发表实验与临床肿瘤学领域的工作，创办于 1979 年。

The title is online only, and it has been fully open access since the fourth day of January in 2024.该刊仅在线上发行，并自 2024 年 1 月 4 日起转为完全开放获取。

In the 2025 edition of the journal citation report it holds an impact factor of 3.3 and stands in the second quartile of oncology.在 2025 年版期刊引证报告中，该刊的影响因子为 3.3，在肿瘤学类目中列第二区。

Scope

• Experimental oncology and clinical oncology are treated together, and the journal does not draw a hard line between the laboratory and the ward.实验肿瘤学与临床肿瘤学被一并处理，该刊不在实验室与病房之间划出硬性的界线。

• Carcinogenesis is named among the subjects, and work on how a normal cell becomes a tumour cell is admitted.癌变被点名为选题之一，关于正常细胞如何变成肿瘤细胞的工作受到收载。

• Molecular biology belongs to the scope, and studies of the genes and the pathways that drive a tumour are taken.分子生物学属于收稿范围，关于驱动肿瘤的基因与通路的研究受到收载。

• Developments in tumour therapy form a central strand, and the journal carries work on new agents and on new ways of using old ones.肿瘤治疗的进展构成中心支线，该刊刊载新药以及旧药新用法方面的工作。

• General and laboratory diagnosis are covered, and the journal takes work on the tests that establish what a patient has.一般诊断与实验室诊断得到覆盖，该刊收载确定患者所患何病的检验方面的工作。

• Diagnostic pathology and experimental pathology appear among the named topics, and the journal follows the reading of tissue under the microscope.诊断病理学与实验病理学见于点名选题，该刊追踪在显微镜下阅读组织的做法。

• Oncologic surgery is part of the remit, and studies of the operative treatment of a tumour are admitted.肿瘤外科是收稿范围的一部分，关于肿瘤手术治疗的研究也在接纳之列。

• Epidemiology is named, and the journal carries work on the frequency of cancer and on the factors that raise or lower the risk.流行病学被点名，该刊刊载癌症发生频率以及影响风险升降的因素方面的研究。

• Biomarkers are treated as a subject, and work that ties a measurable quantity to a diagnosis or to a prognosis is taken.生物标志物自成一个选题，把可测量与诊断或预后联系起来的工作受到收载。

• Precision oncology appears in the pages of the journal, and treatment chosen by the molecular profile of a tumour is followed.精准肿瘤学见于该刊页面，依肿瘤分子图谱择定的治疗受到追踪。

• Immunotherapy is covered, and work on the treatments that turn the immune system against a tumour is admitted.免疫治疗得到覆盖，关于调动免疫系统对付肿瘤的疗法的工作也在接纳之列。

• Clinical trials are treated as part of the scope, and the journal takes reports of studies designed to test a treatment in patients.临床试验被视为收稿范围的一部分，该刊收载为在患者身上检验疗法而设计的研究报告。

• Reviews are carried beside the primary reports, and a review is expected to weigh a body of evidence rather than to list it.综述与原始报告并列刊载，所选综述要求权衡一批证据，而非罗列。

• The journal also publishes material that bears on the organisation of cancer care, since treatment does not happen apart from services.该刊也刊载涉及癌症诊疗组织工作的材料，因为治疗无法脱离服务体系而存在。

• The readership is drawn from oncology, surgery, pathology and radiology, and from the research laboratories that work alongside them.读者来自肿瘤学、外科、病理学与放射学，也来自与它们并肩工作的研究实验室。

• Cancer genomics is a named theme, and the journal has gathered work on how genomic and molecular insight drives drug development.癌症基因组学是点名主题，该刊汇集过基因组与分子洞见如何推动药物开发的工作。

• Cellular therapy has been treated in a collection of its own, and work on engineered immune cells against a tumour is admitted.细胞治疗曾以专门的专题集处理，关于用工程化免疫细胞对付肿瘤的工作也在接纳之列。

• Palliative questions are admitted where they bear on the course of a treated patient, since the journal reads oncology as a whole.姑息方面的问题在其关乎受治患者的病程时受到收载，因为该刊把肿瘤学当作整体来读。

• Case series and retrospective analyses are taken beside trials, and the journal states the conditions under which each is accepted.病例系列与回顾性分析同试验一并收载，该刊说明各自获接纳的条件。

• The journal is read in cancer centres, in universities and in laboratories, and its papers are expected to speak to more than one of them.该刊在癌症中心、高校与实验室中被阅读，其论文被期待能对其中不止一处说话。

• Authors are asked to report their methods in full, so that a result can be reproduced by a group that did not do the work.作者须完整报告方法，使未参与该项工作的团队也能重现结果。

History

• The journal dates from 1979, when the first volume under the present title was gathered as volume 93.该刊可上溯到 1979 年，现名之下的第 1 卷以第 93 卷的编号成册。

• That numbering shows the title to continue an older German series of cancer research periodicals, and the journal keeps that inheritance in view.这一编号显示该刊承接了一份更早的德文癌症研究期刊系列，刊物始终记着这份承继。

• The journal has been published throughout by Springer, working from Berlin and New York.该刊自始至终由 Springer 出版，办公地点在柏林与纽约。

• It is now an online only publication, and the printed edition has been discontinued.该刊如今只作线上出版物，印刷版已经停出。

• The print number is 0171-5216 and the electronic number is 1432-1335, though the printed form is no longer issued.印刷版编号为 0171-5216，电子版编号为 1432-1335，印刷形式已不再发行。

• Twelve issues are gathered into each volume, and the journal has kept a monthly rhythm.每卷汇集十二期，该刊保持着月刊的节奏。

• MEDLINE and PubMed have carried the title from its first volume in 1979, and it also appears in Index Medicus and in PubMed Central.MEDLINE 与 PubMed 自 1979 年的第 1 卷起收录该刊，它也见于 Index Medicus 与 PubMed Central。

• The impact indicator has moved from 4.553 and 4.322 to 2.7 and 2.8, and it stood at 3.3 in the 2025 edition.影响因子从 4.553 与 4.322 变为 2.7 与 2.8，在 2025 年版为 3.3。

• The journal became fully open access on the fourth of January 2024, and its first wholly open issue was the February number of that year.该刊于 2024 年 1 月 4 日转为完全开放获取，其首个完全开放的期号是当年二月的期号。

• The change means that every paper is now freely available to readers worldwide, and reuse is permitted under the terms the publisher sets.这一转变意味着如今每篇论文都可为全世界的读者免费获取，并可在出版方设定的条款下再利用。

• The median time from submission to a first decision is given as two days, which is unusually quick for a clinical journal.从投稿到首次决定的中位时长记为两天，对一份临床期刊而言快得出奇。

• The journal reports a wide readership, with more than two and a half million downloads in a recent year.该刊报告的读者面较广，近一年内的下载量超过二百五十万次。

• The journal is read by oncologists, pathologists and laboratory scientists, and a paper is expected to be legible to all three.该刊的读者包括肿瘤科医生、病理科医生与实验室科学家，论文被期待这三类人都能读懂。

Editors

• The editor-in-chief is Alwin Krämer, who holds a doctorate in medicine.主编是（Alwin Krämer），拥有医学博士学位。

• The journal is the official organ of the German Cancer Society, and the society is named on its pages as the body it serves.该刊是德国癌症学会的正式会刊，学会在刊物页面上被列为它所服务的机构。

• An editorial board covers the branches of oncology that the journal takes, from molecular work to surgery.一支编委会覆盖该刊所收肿瘤学的各个分支，从分子工作一直到外科。

• Associate editors handle the flow of manuscripts, and they are drawn from cancer centres in several countries.若干副编辑处理稿件流，他们来自数个国家的癌症中心。

• Manuscripts are submitted through the publisher's online system and are sent to independent referees for peer review.稿件通过出版方的在线系统投递，并送交独立审稿人进行同行评审。

• A pre-submission checklist is offered to authors, and the journal publishes detailed guidelines for preparing a paper.刊物为作者提供投稿前检查清单，并公布论文准备的详细指南。

• Since the journal is fully open access, a charge is levied on accepted papers, and waiver routes are published for authors who need them.由于该刊完全开放获取，录用的论文须缴费，刊物也为有需要的作者公布减免途径。

• Authors are asked to declare competing interests and to follow the publisher's policy on research integrity.作者须声明利益冲突，并遵循出版方的研究诚信政策。

• Collections are opened on defined questions, and recent ones have taken in cell therapy and cancer genomics.专题集围绕明确问题开放，近期的几辑涵盖细胞治疗与癌症基因组学。

• The editorial office answers queries by email and guides authors through submission and revision.编辑部以电子邮件答复查询，并引导作者完成投稿与修回。